|
|
Etude de phase II sur l’efficacité et la tolérance d’une augmentation de dose de radiothérapie des lésions hypoxiques définies par TEP-scanographie au fluoromisonidazole chez les patients suivis pour un cancer bronchique non à petites cellules
Sébastien Thureau
,
Philippe Chaumet Riffaud
,
Romain Modzelewski
,
Sébastien Hapdey
,
Marc Mahé
,
et al.
Congrès de la Société Française de Radiothérapie et Oncologie, 2016, Paris, France
Conference poster
hal-01665300v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors
Sandrine Hiret
,
Nicolas Isambert
,
Carlos Gomez-Roca
,
Jaafar Bennouna
,
Mouna Sassi
,
et al.
Journal articles
hal-01960201v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
Nicolas Penel
,
Olivier Mir
,
Jennifer Wallet
,
Isabelle Ray-Coquard
,
Axel Le Cesne
,
et al.
Journal articles
hal-03623680v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Exercise training improves radiotherapy efficiency in a murine model of prostate cancer
Suzanne Dufresne
,
Jordan Guéritat
,
Sophie Chiavassa
,
Caroline Noblet
,
Mohamad Assi
,
et al.
Journal articles
hal-02498421v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Predictive Power of FDG-PET Parameters at Diagnosis and after Induction in Patients with Mantle Cell Lymphoma, Interim Results from the LyMa-PET Project, Conducted on Behalf of the Lysa Group
Caroline Bodet-Milin
,
Clément Bailly
,
Michel Meignan
,
Alina Beriollo-Riedinger
,
René-Olivier Casasnovas
,
et al.
Blood, 2015, 126 (23), pp.335
Journal articles
hal-01300802v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of body mass index on overall survival in patients with metastatic breast cancer
Khalil Saleh
,
Matthieu Carton
,
Véronique Dieras
,
Pierre-Etienne Heudel
,
Etienne Brain
,
et al.
Journal articles
hal-03345238v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas
Maud Toulmonde
,
Nicolas Penel
,
Julien Adam
,
Christine Chevreau
,
Jean-Yves Blay
,
et al.
Journal articles
hal-01708092v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups
I. Amblard
,
F. Mercier
,
D.L. Bartlett
,
S.A. Ahrendt
,
K.W. Lee
,
et al.
Journal articles
hal-02281342v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial
C. Delbaldo
,
M. Ychou
,
A. Zawadi
,
J. Douillard
,
T. André
,
et al.
Journal articles
hal-02285403v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
Damien Pouessel
,
Sylvie Chevret
,
Frédéric Rolland
,
Gwenaëlle Gravis
,
Lionel Geoffrois
,
et al.
Journal articles
hal-01278607v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept
Florent Vilotte
,
Mickael Antoine
,
Maxime Bobin
,
Igor Latorzeff
,
Stéphane Supiot
,
et al.
Journal articles
hal-01502241v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Updated Incidence of Thymic Epithelial Tumors (TET) in France and Clinical Presentation at Diagnosis
Maria Bluthgen
,
Eric Dansin
,
Mallorie Kerjouan
,
Julien Mazieres
,
Eric Pichon
,
et al.
Journal articles
hal-01774363v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer
C. Bascoul-Mollevi
,
S. Gourgou
,
M.-P. Galais
,
J.-L. Raoul
,
O. Bouche
,
et al.
Journal articles
hal-01688845v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Validation of the prognostic impact of lymphocyte infiltration (LI) in patients (pts) with stage III colon cancer (CC) treated with adjuvant FOLFOX plus /- cetuximab: A PETACC8 translational study
Jean-François Emile
,
Karine Le Malicot
,
Josep Tabernero
,
Enrico Mini
,
Gunnar Folprecht
,
et al.
Gastrointestinal Cancers Symposium, ASCO University, Jan 2016, San Francisco, United States. pp.Meeting Abstract: 553
Conference papers
hal-01490356v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial
Stéphane Culine
,
Valentin Harter
,
Gwenaelle Gravis
,
Aude Fléchon
,
Christine Chevreau
,
et al.
Journal articles
hal-03625944v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors
Sabrina Croce
,
Agnès Ducoulombier
,
Agnès Ribeiro
,
Tom Lesluyes
,
Jean-Christophe Noel
,
et al.
Journal articles
hal-01926566v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
EP-1998: In silico modelling of the impact of the fractionation for hypofractionated prostate treatments
G. Delpon
,
J. N'Guessan
,
Perrine Paul-Gilloteaux
,
K. Clément-Colmou
,
V. Potiron
,
et al.
Journal articles
hal-02736053v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Delineation guidelines for the lymphatic target volumes in ‘prone crawl’ radiotherapy treatment position for breast cancer patients
Guillaume Janoray
,
Yoann Pointreau
,
Marc Alfonsi
,
Christian Sire
,
Lionel Geoffrois
,
et al.
Journal articles
hal-03657494v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Mitotic stress-induced secretome primes cancer cells to apoptosis and maximizes paclitaxel response in breast tumors when combined with BCL-xL-targeting BH3 mimetics
Steven Lohard
,
Philippe Juin
,
Sophie C Barillé-Nion
Journal articles
inserm-03319352v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Faecal calprotectin is highly effective to detect endoscopic ulcerations in Crohn's disease regardless of disease location
A. Buisson
,
W. Y. Mak
,
M. J. Andersen
,
D. Lei
,
J. Pekow
,
et al.
13. Congress of ECCO - European Crohn's and Colitis Organisation, Feb 2018, Vienne, Austria
Conference papers
hal-02734755v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Emotional processes in partners’ quality of life at various stages of breast cancer pathway: a longitudinal study
Anne-Sophie Baudry
,
Laurence Vanlemmens
,
Anne Congard
,
Aurélie Untas
,
Carine Segura-Djezzar
,
et al.
Journal articles
hal-03991505v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical Trial
C. Falandry
,
F. Rousseau
,
M. A. Mouret-Reynier
,
F. Tinquaut
,
D. Lorusso
,
et al.
Journal articles
inserm-03344388v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients
Aurore Goineau
,
Loïc Campion
,
Bénédicte d'Aillières
,
Brigitte Vié
,
Agnès Ghesquière
,
et al.
Journal articles
hal-03612970v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Société Française de lutte contre les Cancers de l'Enfant (SFCE) from 2000 to 2013
Anne Ducassou
,
Laetitia Padovani
,
Leonor L. Chaltiel
,
Stéphanie Bolle
,
Jean-Louis Habrand
,
et al.
Journal articles
hal-02478966v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit
Alexandre de Nonneville
,
Camille Jauffret
,
Anthony Gonçalves
,
Jean-Marc Classe
,
Monique Cohen
,
et al.
Journal articles
hal-02419353v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Brief report: High prevalence of somatic oncogenic driver alterations in non-small cell lung cancer patients with Li-Fraumeni Syndrome
Laura Mezquita
,
Maria Jove
,
Ernest Nadal
,
Maria Kfoury
,
Teresa Morán
,
et al.
Journal articles
hal-02534435v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy
Raoudha Boughzala-Bennadji
,
Eberhard Stoeckle
,
Cécile Le Péchoux
,
Pierre Méeus
,
Charles Honoré
,
et al.
Journal articles
hal-02049039v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
[COVID-19 and People Followed for Breast Cancer: French Guidelines for Clinical Practice of Nice-St Paul De Vence, in Collaboration With the Collège Nationale Des Gynécologues Et Obstétriciens Français (CNGOF), the Société d'Imagerie De La Femme (SIFEM), the Société Française De Chirurgie Oncologique (SFCO), the Société Française De Sénologie Et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)]
Joseph Gligorov
,
Thomas Bachelot
,
Jean-Yves Pierga
,
Eric-Charles Antoine
,
Corinne Balleyguier
,
et al.
Journal articles
hal-02869600v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study
A. de Nonneville
,
A. Goncalves
,
C. Zemmour
,
M. Cohen
,
J.M. Classe
,
et al.
Journal articles
hal-02282824v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial
Amit Oza
,
Ursula Matulonis
,
Susanne Malander
,
Stacie Hudgens
,
Jalid Sehouli
,
et al.
Journal articles
hal-02283098v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|